mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells

Age-related macular degeneration (AMD) is a complex degenerative disease of the retina with multiple risk-modifying factors, including aging, genetics, and lifestyle choices. The combination of these factors leads to oxidative stress, inflammation, and metabolic failure in the retinal pigment epithe...

Full description

Bibliographic Details
Main Authors: David A. Merle, Francesca Provenzano, Mohamed Ali Jarboui, Ellen Kilger, Simon J. Clark, Michela Deleidi, Angela Armento, Marius Ueffing
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/10/12/1944
_version_ 1797506886642171904
author David A. Merle
Francesca Provenzano
Mohamed Ali Jarboui
Ellen Kilger
Simon J. Clark
Michela Deleidi
Angela Armento
Marius Ueffing
author_facet David A. Merle
Francesca Provenzano
Mohamed Ali Jarboui
Ellen Kilger
Simon J. Clark
Michela Deleidi
Angela Armento
Marius Ueffing
author_sort David A. Merle
collection DOAJ
description Age-related macular degeneration (AMD) is a complex degenerative disease of the retina with multiple risk-modifying factors, including aging, genetics, and lifestyle choices. The combination of these factors leads to oxidative stress, inflammation, and metabolic failure in the retinal pigment epithelium (RPE) with subsequent degeneration of photoreceptors in the retina. The alternative complement pathway is tightly linked to AMD. In particular, the genetic variant in the complement factor H gene (<i>CFH</i>), which leads to the Y402H polymorphism in the factor H protein (FH), confers the second highest risk for the development and progression of AMD. Although the association between the FH Y402H variant and increased complement system activation is known, recent studies have uncovered novel FH functions not tied to this activity and highlighted functional relevance for intracellular FH. In our previous studies, we show that loss of <i>CFH</i> expression in RPE cells causes profound disturbances in cellular metabolism, increases the vulnerability towards oxidative stress, and modulates the activation of pro-inflammatory signaling pathways, most importantly the NF-kB pathway. Here, we silenced <i>CFH</i> in hTERT-RPE1 cells to investigate the mechanism by which intracellular FH regulates RPE cell homeostasis. We found that silencing of <i>CFH</i> results in hyperactivation of mTOR signaling along with decreased mitochondrial respiration and that mTOR inhibition via rapamycin can partially rescue these metabolic defects. To obtain mechanistic insight into the function of intracellular FH in hTERT-RPE1 cells, we analyzed the interactome of FH via immunoprecipitation followed by mass spectrometry-based analysis. We found that FH interacts with essential components of the ubiquitin-proteasomal pathway (UPS) as well as with factors associated with RB1/E2F signalling in a complement-pathway independent manner. Moreover, we found that FH silencing affects mRNA levels of the E3 Ubiquitin-Protein Ligase Parkin and PTEN induced putative kinase (Pink1), both of which are associated with UPS. As inhibition of mTORC1 was previously shown to result in increased overall protein degradation via UPS and as FH mRNA and protein levels were shown to be affected by inhibition of UPS, our data stress a potential regulatory link between endogenous FH activity and the UPS.
first_indexed 2024-03-10T04:38:50Z
format Article
id doaj.art-a96bde4bc24e4a1698fe33f4427a320d
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-10T04:38:50Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-a96bde4bc24e4a1698fe33f4427a320d2023-11-23T03:33:18ZengMDPI AGAntioxidants2076-39212021-12-011012194410.3390/antiox10121944mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE CellsDavid A. Merle0Francesca Provenzano1Mohamed Ali Jarboui2Ellen Kilger3Simon J. Clark4Michela Deleidi5Angela Armento6Marius Ueffing7Institute for Ophthalmic Research, Department for Ophthalmology, Eberhard Karls University of Tübingen, 72076 Tübingen, GermanyGerman Center for Neurodegenerative Diseases (DZNE), 72076 Tübingen, GermanyInstitute for Ophthalmic Research, Department for Ophthalmology, Eberhard Karls University of Tübingen, 72076 Tübingen, GermanyInstitute for Ophthalmic Research, Department for Ophthalmology, Eberhard Karls University of Tübingen, 72076 Tübingen, GermanyInstitute for Ophthalmic Research, Department for Ophthalmology, Eberhard Karls University of Tübingen, 72076 Tübingen, GermanyGerman Center for Neurodegenerative Diseases (DZNE), 72076 Tübingen, GermanyInstitute for Ophthalmic Research, Department for Ophthalmology, Eberhard Karls University of Tübingen, 72076 Tübingen, GermanyInstitute for Ophthalmic Research, Department for Ophthalmology, Eberhard Karls University of Tübingen, 72076 Tübingen, GermanyAge-related macular degeneration (AMD) is a complex degenerative disease of the retina with multiple risk-modifying factors, including aging, genetics, and lifestyle choices. The combination of these factors leads to oxidative stress, inflammation, and metabolic failure in the retinal pigment epithelium (RPE) with subsequent degeneration of photoreceptors in the retina. The alternative complement pathway is tightly linked to AMD. In particular, the genetic variant in the complement factor H gene (<i>CFH</i>), which leads to the Y402H polymorphism in the factor H protein (FH), confers the second highest risk for the development and progression of AMD. Although the association between the FH Y402H variant and increased complement system activation is known, recent studies have uncovered novel FH functions not tied to this activity and highlighted functional relevance for intracellular FH. In our previous studies, we show that loss of <i>CFH</i> expression in RPE cells causes profound disturbances in cellular metabolism, increases the vulnerability towards oxidative stress, and modulates the activation of pro-inflammatory signaling pathways, most importantly the NF-kB pathway. Here, we silenced <i>CFH</i> in hTERT-RPE1 cells to investigate the mechanism by which intracellular FH regulates RPE cell homeostasis. We found that silencing of <i>CFH</i> results in hyperactivation of mTOR signaling along with decreased mitochondrial respiration and that mTOR inhibition via rapamycin can partially rescue these metabolic defects. To obtain mechanistic insight into the function of intracellular FH in hTERT-RPE1 cells, we analyzed the interactome of FH via immunoprecipitation followed by mass spectrometry-based analysis. We found that FH interacts with essential components of the ubiquitin-proteasomal pathway (UPS) as well as with factors associated with RB1/E2F signalling in a complement-pathway independent manner. Moreover, we found that FH silencing affects mRNA levels of the E3 Ubiquitin-Protein Ligase Parkin and PTEN induced putative kinase (Pink1), both of which are associated with UPS. As inhibition of mTORC1 was previously shown to result in increased overall protein degradation via UPS and as FH mRNA and protein levels were shown to be affected by inhibition of UPS, our data stress a potential regulatory link between endogenous FH activity and the UPS.https://www.mdpi.com/2076-3921/10/12/1944retinal pigment epithelium (RPE) cellsage-related macular degeneration (AMD)complement factor H (<i>CFH</i>/FH)mammalian target of rapamycin (mTOR)mitochondrial respirationinteractome
spellingShingle David A. Merle
Francesca Provenzano
Mohamed Ali Jarboui
Ellen Kilger
Simon J. Clark
Michela Deleidi
Angela Armento
Marius Ueffing
mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells
Antioxidants
retinal pigment epithelium (RPE) cells
age-related macular degeneration (AMD)
complement factor H (<i>CFH</i>/FH)
mammalian target of rapamycin (mTOR)
mitochondrial respiration
interactome
title mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells
title_full mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells
title_fullStr mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells
title_full_unstemmed mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells
title_short mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells
title_sort mtor inhibition via rapamycin treatment partially reverts the deficit in energy metabolism caused by fh loss in rpe cells
topic retinal pigment epithelium (RPE) cells
age-related macular degeneration (AMD)
complement factor H (<i>CFH</i>/FH)
mammalian target of rapamycin (mTOR)
mitochondrial respiration
interactome
url https://www.mdpi.com/2076-3921/10/12/1944
work_keys_str_mv AT davidamerle mtorinhibitionviarapamycintreatmentpartiallyrevertsthedeficitinenergymetabolismcausedbyfhlossinrpecells
AT francescaprovenzano mtorinhibitionviarapamycintreatmentpartiallyrevertsthedeficitinenergymetabolismcausedbyfhlossinrpecells
AT mohamedalijarboui mtorinhibitionviarapamycintreatmentpartiallyrevertsthedeficitinenergymetabolismcausedbyfhlossinrpecells
AT ellenkilger mtorinhibitionviarapamycintreatmentpartiallyrevertsthedeficitinenergymetabolismcausedbyfhlossinrpecells
AT simonjclark mtorinhibitionviarapamycintreatmentpartiallyrevertsthedeficitinenergymetabolismcausedbyfhlossinrpecells
AT micheladeleidi mtorinhibitionviarapamycintreatmentpartiallyrevertsthedeficitinenergymetabolismcausedbyfhlossinrpecells
AT angelaarmento mtorinhibitionviarapamycintreatmentpartiallyrevertsthedeficitinenergymetabolismcausedbyfhlossinrpecells
AT mariusueffing mtorinhibitionviarapamycintreatmentpartiallyrevertsthedeficitinenergymetabolismcausedbyfhlossinrpecells